The 10 Most Heavily Shorted Bio-Pharma Stocks

The 10 biotech and drug stocks with the largest short interest as percentage of float, according to S&P CapitalIQ:

10. Spectrum Pharmaceuticals (SPPI) (26.8% shares short)


^NBI Chart
^NBI data by YCharts

9. Dendreon (DNDN) (29.6% shares short)

DNDN Chart
DNDN data by YCharts

8. Achillion Pharma (ACHN) (29.7% shares short)


^NBI Chart
^NBI data by YCharts

7. Arena Pharmaceuticals (ARNA) (29.9% shares short)


ARNA Chart
ARNA data by YCharts

6. Ziopharm (ZIOP) (30.9% shares short)


ZIOP Chart
ZIOP data by YCharts

5. Intrexon (XON) (32.8% shares short)


XON Chart
XON data by YCharts

4. Idenix Pharma (IDIX) (33.3% shares short)


IDIX Chart
IDIX data by YCharts

3. Synta Pharma (SNTA) (36.4% shares short)


SNTA Chart
SNTA data by YCharts

2. Sarepta Therapeutics (SRPT) (39% shares short)


SRPT Chart
SRPT data by YCharts

1. Myriad Genetics (MYGN) (52.4% shares short)


MYGN Chart
MYGN data by YCharts

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

More from Investing

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Trump's Oil Tweets Ruining the Stock Market's Rebound?

Trump's Oil Tweets Ruining the Stock Market's Rebound?

A BJ's Wholesale IPO Is Logical Next Step

A BJ's Wholesale IPO Is Logical Next Step

Tesla Investor Pushing for More Board Changes

Tesla Investor Pushing for More Board Changes

What You Need to Know About Facebook and Europe's New Privacy Rules

What You Need to Know About Facebook and Europe's New Privacy Rules